Veterinary Medicines

Epispas ReVet RV10 - Injektionslösung für Tiere

Authorised
  • Citrullus colocynthis C6
  • CUPRUM METALLICUM C9
  • Hyoscyamus niger C6
  • LACHESIS C9
Download as PDF

Product identification

Medicine name:
Epispas ReVet RV10 - Injektionslösung für Tiere
Active substance:
  • Citrullus colocynthis C6
  • CUPRUM METALLICUM C9
  • Hyoscyamus niger C6
  • LACHESIS C9
Target species:
  • Pigeon
  • Reptile
  • Ornamental bird
  • Dog
  • Cat
  • Rabbit
  • Ferret
  • Small rodents
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Citrullus colocynthis C6
    0.25
    gram(s)
    /
    1.00
    millilitre(s)
  • CUPRUM METALLICUM C9
    0.25
    gram(s)
    /
    1.00
    millilitre(s)
  • Hyoscyamus niger C6
    0.25
    gram(s)
    /
    1.00
    millilitre(s)
  • LACHESIS C9
    0.25
    gram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pigeon
      • Meat and offal
        0
        day
    • Reptile
    • Ornamental bird
    • Dog
    • Cat
    • Rabbit
      • Meat and offal
        0
        day
    • Ferret
    • Small rodents
  • Intravenous use
    • Reptile
    • Dog
    • Cat
    • Rabbit
      • Meat and offal
        0
        day
    • Ferret
    • Small rodents
  • Subcutaneous use
    • Pigeon
      • Meat and offal
        0
        day
    • Reptile
    • Ornamental bird
    • Dog
    • Cat
    • Rabbit
      • Meat and offal
        0
        day
    • Ferret
    • Small rodents
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Homeopathic medicinal products (Article 19 of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharmazeutische Fabrik Dr. Reckeweg & Co. GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmazeutische Fabrik Dr. Reckeweg & Co. GmbH
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-30041
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/07/2014
Updated on: 9/07/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/07/2014
Updated on: 9/07/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/07/2014
Updated on: 9/07/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."